Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on July 23, 2007
Chest, doi:10.1378/chest.07-0128
doi:10.1378/chest.07-0128
(Chest. 2007; 132:1291-1297)
© 2007 American College of Chest Physicians
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.07-0128v1
132/4/1291    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korosec, P.
Right arrow Articles by Kosnik, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korosec, P.
Right arrow Articles by Kosnik, M.

Expansion of Pulmonary CD8+CD56+ Natural Killer T-Cells in Hypersensitivity Pneumonitis*

Peter Korosec, PhD; Katarina Osolnik, MD; Izidor Kern, MD; Mira Silar, BSc; Katja Mohorcic, MD and Mitja Kosnik, PhD, MD

* From the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.

Correspondence to: Peter Korosec, PhD, Laboratory of Immunology and Molecular Biology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia; e-mail: peter.korosec{at}klinika-golnik.si

Abstract

Background: Natural killer T (NKT) cells, a newly identified subgroup of T cells with immunoregulatory function, may be implicated in the pathogenesis of interstitial lung disease (ILD).

Methods: We used multiparameter flow cytometry with antibodies to CD3, CD4, CD8, CD14, CD19, CD45, CD16/56, CD56, CD161, and V{alpha}24 invariant T-cell receptor (TCR) in BAL fluid (BALF) to examine the frequency and distribution of pulmonary NKT cells in several cases of ILD. We included 57 patients with sarcoidosis and 17 patients with hypersensitivity pneumonitis.

Results: We found significantly higher frequencies of pulmonary NKT cells in patients with hypersensitivity pneumonitis in comparison to the other study patients with ILD (median proportion of NKT cells, 11%; range, 3 to 38%; vs 3%; range, 0 to 16%; p < 0.0001). In contrast, there was no difference in the proportion of conventional natural killer cells. We found that a major subset of NKT cells in the BALF of patients with hypersensitivity pneumonitis was a CD8+CD56+ population that did not express the invariant TCR.

Conclusions: These results suggest the involvement of NKT cells in the pathogenesis of hypersensitivity pneumonitis.

Key Words: interstitial lung diseases • hypersensitivity pneumonitis • natural killer T cells







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Chest Physicians.